Search Results

You searched for : TreatmentforHIV  

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ...
Jun 22

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left....
Dec 11

Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1

Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women...
Nov 16

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ...
Oct 16

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1

Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections...
Oct 08

9 Matching result(s) found!

-Advertisements-




Trending Now

Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
Candy flavoured traps to hook the next generationMay 31, 2024
Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
AI software could revolutionise voice box cancer treatmentMay 29, 2024
Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024